MediWound Ltd.
MDWD
Rank in Stocks
#17088
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and... MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Share Price
$14.08
Last synced: 2026-11-09
Market Cap
$181.78M
Change (1 day)
-1.19%
Change (1 year)
-22.72%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade MediWound Ltd. (MDWD)
Category
Healthcare
EPS for MediWound Ltd. (MDWD)
EPS as of June 2026 TTM: $-1.60
According to MediWound Ltd.'s latest financial reports, its current EPS (TTM) is $-1.60. At the end of 2025 the company had an EPS of $-2.10, an increase over its 2024 EPS of $-3.03.
EPS history for MediWound Ltd. from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.60 | -23.81% |
| 2025 | $-2.10 | -30.69% |
| 2024 | $-3.03 | 304.00% |
| 2023 | $-0.75 | -80.92% |
| 2022 | $-3.93 | 12.93% |
| 2021 | $-3.48 | 46.22% |
| 2020 | $-2.38 | -288.89% |
| 2019 | $1.26 | -550.00% |
| 2018 | $-0.28 | -95.78% |
| 2017 | $-6.64 | 9.75% |
| 2016 | $-6.05 | -15.15% |
| 2015 | $-7.13 | 7.22% |
| 2014 | $-6.65 | 25.95% |
| 2013 | $-5.28 | -240.43% |
| 2012 | $3.76 | -277.36% |
| 2011 | $-2.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,078.75% |
US
|
|
| $-7.07 | 341.88% |
US
|
|
| $-5.29 | 230.63% |
AU
|
|
| $12.88 | -905.01% |
BE
|
|
| $21.56 | -1,447.50% |
NL
|
Questions about MediWound Ltd.'s earnings per share (EPS)
What is MediWound Ltd.'s earnings per share (EPS)?
MediWound Ltd.'s earnings per share (EPS) over the last twelve months is $-1.60, as of Jun 2026.
What was MediWound Ltd.'s earnings per share (EPS) in 2025?
In 2025, MediWound Ltd.'s earnings per share (EPS) was $-2.10, compared with $-3.03 in 2024.
How has MediWound Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, MediWound Ltd.'s earnings per share (EPS) was highest in 2023 ($-0.75) and lowest in 2022 ($-3.93).
How does MediWound Ltd.'s earnings per share (EPS) compare with similar companies?
MediWound Ltd.'s earnings per share (EPS) ($-1.60) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.